Aardema H, Arends J P, de Smet A M G A, Zijlstra J G
Department of Critical Care, University Medical Center Groningen, the Netherlands.
Neth J Med. 2015 May;73(4):169-74.
The occurrence of highly resistant microorganisms (HRMOs) is a major threat to critical care patients, leading to worse outcomes, need for isolation measures, and demand for second-line or rescue antibiotics. The aim of this study was to quantify the burden of HRMOs in an intensive care unit (ICU) for adult patients in a university hospital in the Netherlands. We evaluated local distribution of different HRMO categories and proportion of ICU-imported versus ICU- acquired HRMOs. Outcome of HRMO-positive patients versuscontrols was compared.
In this prospective single-centre study, culture results of all ICU patients during a four-month period were recorded, as well as APACHE scores, ICU mortality and length of stay (LOS) in the ICU.
58 of 962 (6.0%) patients were HRMO positive during ICU stay. The majority (60%) of those patients were HRMO positive on ICU admission. HRMO-positive patients had significantly higher APACHE scores, longer LOS and higher mortality compared with controls.
Our study suggests that a large part of antibiotic resistance in the ICU is imported. This underscores the importance of a robust surveillance and infection control program throughout the hospital, and implies that better recognition of those at risk for HRMO carriage before ICU admission may be worthwhile. Only a small minority of patients with HRMO at admission did not have any known risk factors for HRMO.
高耐药性微生物(HRMOs)的出现对重症监护患者构成重大威胁,导致更差的预后、需要采取隔离措施以及对二线或挽救性抗生素的需求。本研究的目的是量化荷兰一家大学医院成人重症监护病房(ICU)中HRMOs的负担。我们评估了不同HRMO类别在当地的分布情况以及ICU输入性与ICU获得性HRMOs的比例。比较了HRMO阳性患者与对照组的结局。
在这项前瞻性单中心研究中,记录了四个月期间所有ICU患者的培养结果,以及急性生理学与慢性健康状况评分系统(APACHE)评分、ICU死亡率和在ICU的住院时间(LOS)。
962例患者中有58例(6.0%)在ICU住院期间HRMO呈阳性。这些患者中的大多数(60%)在入住ICU时HRMO呈阳性。与对照组相比,HRMO阳性患者的APACHE评分显著更高、住院时间更长且死亡率更高。
我们的研究表明,ICU中的很大一部分抗生素耐药性是输入性的。这凸显了在整个医院建立强有力的监测和感染控制计划的重要性,并意味着在入住ICU之前更好地识别那些有携带HRMO风险的人可能是值得的。入院时HRMO阳性的患者中只有一小部分没有任何已知的HRMO风险因素。